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Background: Marek’s disease (MD) is a neoplastic disease in chickens caused by the MD virus (MDV). Successful
vaccine development against MD has resulted in increased virulence of MDV and the understanding of genetic
resistance to the disease is, therefore, crucial to long-term control strategies. Also, epigenetic factors are believed to
be one of the major determinants of disease response.
Results: Here, we carried out comprehensive analyses of the epigenetic landscape induced by MDV, utilizing
genome-wide histone H3 lysine 4 and lysine 27 trimethylation maps from chicken lines with varying resistance to
MD. Differential chromatin marks were observed on genes previously implicated in the disease such as MX1 and
CTLA-4 and also on genes reported in other cancers including IGF2BP1 and GAL. We detected bivalent domains on
immune-related transcriptional regulators BCL6, CITED2 and EGR1, which underwent dynamic changes in both lines
as a result of MDV infection. In addition, putative roles for GAL in the mechanism of MD progression were revealed.
Conclusion: Our results confirm the presence of widespread epigenetic differences induced by MD in chicken lines
with different levels of genetic resistance. A majority of observed epigenetic changes were indicative of increased
levels of viral infection in the susceptible line symptomatic of lowered immunocompetence in these birds caused
by early cytolytic infection. The GAL system that has known anti-proliferative effects in other cancers is also revealed
to be potentially involved in MD progression. Our study provides further insight into the mechanisms of MD
progression while revealing a complex landscape of epigenetic regulatory mechanisms that varies depending on
host factors.
Keywords: Histone modifications, Thymus, Differential marks, Bivalent domain, Chromatin signature, Marek’s diseaseBackground
Rapid advances in epigenetics have led to the discovery
of complex mechanisms of gene regulation involving
phenomena such as DNA methylation and chromatin
modifications. Methylation of particular histone residues
has been found to correlate with specific and often op-
posing cellular functions, e.g. trimethylation of histone
H3 lysine 4 (H3K4me3) is associated with transcriptional
start sites (TSSs) of active genes while trimethylation of
histone H3 lysine 27 (H3K27me3) is found to mark
broad genomic regions for repression. Recent studies* Correspondence: songj88@umd.edu
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reproduction in any medium, provided the orhave also suggested that characteristic combinations of
histone modifications or ‘chromatin states’ define func-
tional elements of the genome and determine their con-
tribution to transcriptional regulation [1-3]. Moreover,
the epigenetic state of host genes have been observed to
be affected by viral infection leading to tumors in
humans [4-6]. Thus, epigenetics constitute a dynamic
regulatory framework linking genotypes with environ-
mental factors that could play a major role in differential
disease responses among individuals having high genetic
similarity.
Marek’s disease (MD) is a highly contagious disease
caused by an oncogenic α-herpesvirus MD virus (MDV)
and characterized by T-cell lymphomas in chickens [7].
Major losses to the poultry industry as a result of MD
have largely been averted due to the success of variousd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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instance of the successful control of a natural cancer-
causing agent using vaccines [8-10]. However, the viru-
lence of the virus may have progressively increased as a
consequence of vaccine development [11-13]. Several
reported instances of vaccine breaks or reduced efficacy
of vaccination, therefore, underlines the importance of
investigating resistance to the disease as a long-term
strategy to control MDV.
Natural resistance to MDV can be divided into two
categories: major histocompatibility complex (MHC)-
associated resistance, wherein different MHC haplotypes
at the B blood group locus confer varying levels of re-
sistance and non-MHC associated resistance in which
birds having the same MHC haplotype exhibit vastly dif-
ferent responses to MDV infection. Inbred lines 63 and
72 developed at the Avian Disease and Oncology Labora-
tory (ADOL, East Lansing, MI) that we used in this
study, fall into the latter category. These lines share a
high degree of genetic similarity but have divergent
responses to MDV infection completely independent of
the MHC. Several studies have attempted to pinpoint
factors responsible for conferring resistance [14-16], but
confounding factors, such as, tissue types, virus strains
and ages of birds have made it difficult to find a consen-
sus. Multiple risk elements are possibly at play in this
complex disease, and increased resistance or susceptibil-
ity is likely to be produced by a combination of such fac-
tors. In this study, we take a closer look at epigenetic
factors behind different responses to MD with a view to
a deeper understanding of the broader genomic impact
of MDV infection.
We utilized the above population of inbred chickens –
line 63 is highly resistant to MD, while line 72 is highly
susceptible – and compared the epigenetic effects of
MD. Genome-wide maps of H3K4me3 and H3K27me3
in thymus tissues of birds from these chicken lines atTable 1 Significantly enriched regions (SERs) and associated g
H3K4me3
Samples SERs (%)






Condition-specific 63I,72I 97 (0.7)
63N,72N 47 (0.3)
Ubiquitous 63I,63N,72I,72N 10691 (74
Total 14418
63I: line 63 infected, 63N: line 63 control, 72I: line 72 infected, 72N: line 72 control.the latent stage of MDV infection were generated. We
carried out systematic analyses to find differential chro-
matin marks induced by MDV infection. We also inves-
tigated co-localization patterns of the two chromatin
modifications to detect putative bivalent domains and
the effect of MDV on such domains. The results of our
study confirm that Marek’s disease has far-reaching
effects on the epigenetic landscape of chicken lines with
diverse responses to the virus and, thus, furthers our
understanding of this complex disease.Results
Genome-wide distribution of H3K4me3 and H3K27me3
We performed ChIP-Seq experiments on infected and
uninfected birds from lines 63 and 72 to investigate the
epigenetic effects of MDV infection. More than 76 mil-
lion reads from eight samples were mapped to the
chicken genome yielding 14418 and 24950 significantly
enriched regions (SERs) for H3K4me3 and H3K27me3,
respectively (Table 1). We further classified these regions
as follows: Ubiquitous SERs were found in all samples
and were likely due to similarities in the genetic back-
ground of the chickens. Line-specific SERs were present
in only one line either before or after MDV infection,
while condition-specific SERs appeared in both lines but
only in individuals with the same infection status.
Ubiquitous SERs formed the largest percentage of all
enriched regions, accounting for 74.2% and 23.3% in
H3K4me3 and H3K27me3 samples, respectively. In the
case of H3K4me3, there were large differences in the
number of specific SERs - more than 2000 line-specific
SERs were found in line 63, compared to about 300 in
line 72. Similarly, we found 50% more line-specific SERs
of H3K27me3 in line 63 (6568) compared to line 72
(4494). However, upon closer examination, most of the
line-specific and condition-specific SERs were revealedenes in each sample
H3K27me3
Genes SERs (%) Genes
78 3477 (13.9) 615
71 2514 (10.1) 896
190 577 (2.3) 150
16 1658 (6.6) 451
11 2506 (10) 346
17 330 (1.3) 89
35 2061 (8.3) 579
9 66 (0.3) 22
.2) 9475 5831 (23.4) 2942
10206 24950 7904
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corresponding to regions of low enrichment.
Genes were divided into five regions – promoter, 5’
untranslated region (UTR), exons, introns and 3’ UTR –
and the distribution of SERs across these elements was
probed (Figure 1A). We found a large number of inter-
genic regions marked by H3K27me3, consistent with
high levels of this mark associated with areas of silent
heterochromatin. In the case of H3K4me3, a larger pro-
portion of SERs were found around the promoter, exons
and the 5’ UTR while similar proportions of H3K4me3
and H3K27me3 SERs were present in introns and 3’
UTRs. A comparison of the genomic distributions of
SERs in the different samples (Additional file 1: Figures
S2A, B) showed a similar number of H3K4me3 SERs
across the promoter, exons and the 5’ and 3’ UTRs of
genes. Line 63 contained a higher number of intronic
and intergenic SERs as compared to line 72 although this
did not appear to change as a result of MDV infection.
On the other hand, a greater number of H3K27me3Figure 1 Genomic distribution of SERs and relationship between histo
different genomic elements shows increased levels of H3K4me3 around th
H3K27me3 on intergenic regions. (B-E) Relationship between gene express
modifications around the gene body (B, C) in genes having high (blue), me
positive correlation with gene expression levels while H3K27me3 exhibits a
transcriptional levels (D, E) confirms the same. Similar trends were observedSERs were found in the infected samples although these
levels were similar in the two different lines.
To analyze the relationship between histone modifica-
tions and gene expression, histone modification profiles
surrounding the TSS and gene body were plotted for genes
ranked by their expression level (Additional file 1:
Figures 1B-E and S3-5). As expected, a strong positive cor-
relation was observed between gene expression and
H3K4me3 marks with a distinct peak around the TSS and
little to no enrichment within the gene body. On the other
hand, H3K27me3 showed negative correlation with gene
expression with a peak near the TSS followed by a broad
plateau across the gene body. However, the latter relation-
ship was non-linear – genes with lower expression had
similar levels of H3K27me3 marks and levels were mark-
edly distinct only at higher expression levels (Figure 1C, E).
Differential H3K4me3 marks on genes related to MD
We conducted a comprehensive analysis of genome-
wide chromatin marks to find significant differences inne marks and gene expression. (A) Distribution of SERs over
e promoter region and exons while there are increased levels of
ion and histone marks in infected line 63 birds. Plots of histone
dium (red), low (green) and no activity (brown): H3K4me3 shows
negative relationship. A comparison of epigenetic marks and
in other experimental groups (Additional file 1: Figures S3-5).
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sets of comparisons: First, to assess the influence of
MDV infection within each line, we compared the
infected and the non-infected samples from the same
line. Secondly, the non-infected samples from the two
lines were compared to detect line-specific effects. As a
result of this analysis we found 179 differential
H3K4me3 SERs and 1116 differential H3K27me3 SERs
that mapped to 59 and 66 genes, respectively (Table 2).
A majority of differential SERs were found in the com-
parison between non-infected samples of the two lines
(Additional files 2 and 3) with several observed on genes
that have been associated with MDV infection.
MX1 is a zinc-finger transcription factor that has anti-
viral properties against a large number of viruses. MX1
was upregulated after MDV infection [17] although its
contribution to MD progression is unknown. MDV in-
fection induced a highly significant increase in
H3K4me3 enrichment in the promoter region of MX1 in
both lines (line 63: p = 1.28x10
-7, line 72: p = 4.26x10
-9;
Figure 2A). We observed a concurrent increase in tran-
script levels after MDV infection in line 72 (p = 0.0264;
Figure 2B); MX1 expression in line 63 showed a similar
trend (fold change = 38.22, p=0.085) although mRNA
levels were much lower.
CTLA-4 is a cell surface glycoprotein expressed on
CD4+ and CD8+ T lymphocytes that is a powerful nega-
tive regulator of T-cell activation [18]. The CTLA4 pro-
tein is expressed on T lymphocytes soon after activation
and regulates T-cell proliferation, production of IL-2 and
also supports the function of Treg cells that suppress im-
mune response [19]. Previous studies have reported an
increase in CTLA-4 expression after MDV infection
[20]. We found an increase in H3K4me3 enrichment in
line 72 as a result of MDV infection (p = 0.0003) and
there was a similar trend in line 63 (Figure 2C). Consist-
ent with the above, there was a significant increase in
transcript levels after MDV infection in line 72 (p =
0.04) and a small increase in line 63 (Figure 2D).
MMP2 plays a key role in the degradation of the
extra-cellular matrix, and an increase in expression has
been associated with increasing tumor cell migration







63I vs 63N 9 4 42 1
72I vs 72N 30 13 5 0
63N vs 72N 148 46 1094 65
Total 179 59† 1116 66
*FDR < 0.4. † Some genes are shared between different comparisons. 63I: line
63 infected, 63N: line 63 control, 72I: line 72 infected, 72N: line 72 control.during the neoplastic stage of MD infection in suscep-
tible birds [23] but downregulated in response to MDV
infection during early lytic infection in susceptible and
resistant chickens [17]. We observed a slight increase in
H3K4me3 enrichment after MDV infection in both lines,
while line 72 exhibited significantly lower levels than line
63 (p = 0.0016; Figure 2E). This was coupled with
increased MMP2 expression in line 63 after infection
(p = 0.0068) while there was no such change in line
72 (Figure 2F).Genes related to cancers show epigenetic changes in
response to MD
We observed differential histone marks on several genes
that have been associated with other cancers but not in
the context of MDV infection. Insulin-like growth factor
2 binding protein 1 (IGF2BP1) is an RNA-binding factor
that regulates the translation of mRNAs produced by
certain genes like IGF2 and ACTB. Increased expression
of IGF2BP1 has been implicated in the development and
progression of cancers of various organs, e.g. lung, brain,
breast and colon [24-27]. There was no change in the
H3K4me3 enrichment levels induced by MDV infection
although a significantly higher level of enrichment was
present in line 72 (p = 4.21x10
-13; Figure 3A). Transcript
levels in line 72 were much higher than in line 63, but
reduced in response to MDV infection (p = 0.044)
(Figure 3B).
ELL associated factor 2 (EAF2) is a testosterone regu-
lated apoptosis inducer and tumor suppressor. Inactiva-
tion of EAF2 has been shown to lead to tumors in
multiple organs [28]. There was a significant increase in
H3K27me3 levels after MDV infection in line 63 (p =
0.0414) while among uninfected chickens these levels
were markedly higher in line 72 (p = 0.0138; Figure 3C).
However, EAF2 expression was drastically reduced after
MDV infection in line 72 (p=0.0016) but showed only a
small decrease in line 63 (Figure 3D).
Galanin (GAL) is a neuropeptide that modulates vari-
ous physiological functions, such as, inhibition of insulin
secretion and stimulation of growth hormone secretion.
Three galanin receptors are known (GALR1, 2 and 3):
the expression of GALR1 has anti-proliferative effects
while GALR2 can be both anti- or pro-proliferative in
function. Therefore, the GAL system is considered to be
a promising candidate for detection and treatment of
various cancers [29,30]. We observed an increase in
H3K27me3 levels on GAL after infection in both lines
(Figure 3E). Also, expression levels were significantly
lowered after MDV infection in line 72 (p = 0.00087)
while there was a similar trend in line 63 (p = 0.051;
Figure 3F). Interestingly, GALR1 had both H3K4me3
and H3K27me3 enrichments (Figure 4) although GALR2
Figure 2 Genes related to MD show differential H3K4me3 marks. MX1 (A, B) and CTLA-4 (C, D) show increased H3K4me3 marks and higher
expression in infected individuals from both lines; MMP2 (E, F) exhibits higher levels of H3K4me3 in susceptible line 72. n = 4; * = significant at
p < 0.05; ** = significant at p < 0.01; *** = significant at p < 0.001.
Figure 3 MD induces epigenetic changes in genes related to various cancers. IGF2BP1 (A, B) shows differential H3K4me3 marks
and increased expression in susceptible birds while EAF2 (C, D) and GAL (E, F) have differential H3K27me3 levels on the gene body. n = 4;
* = significant at p < 0.05; ** = significant at p < 0.01; *** = significant at p < 0.001.
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Figure 4 Significant H3K4me3 and H3K27me3 enrichment
around GALR1. The anti-proliferative GAL receptor GALR1 exhibited
both active and repressive marks. There is no change in H3K4me3
levels but a definite increase in H3K27me3 levels after infection in
line 72.
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Figure S6).
Chromatin co-localization patterns reveal putative
bivalent genes
Regions of chromatin having both active and repressive
marks are said to be bivalent and have been shown to
play important roles in development and genetic imprint-
ing [31,32]. For example, bivalent domains have been
shown to mark promoters of genes that are subsequently
silenced in tumors by DNA hypermethylation indicating
their importance in cancer [33]. A mono-allelic bivalent
chromatin domain that controls tissue-specific genomic
imprinting at a specific locus was recently found in
mice [32]. To investigate the presence of such bivalent
chromatin states and the possible effect of MDV infec-
tion, we defined bivalent genes as those having
H3K4me3 reads (TSS ± 500 bp) greater than 30 reads
per million mapped reads (RPM) and H3K27me3 reads
(gene body) greater than 2 RPM, respectively (~85th
percentile). This filtering process yielded a list of 99
putative bivalent genes (Additional file 4).
Functional annotation clustering of the above genes
using DAVID [34,35] revealed significant enrichment of
several immune-related functions. These included tran-
scription factor EGR1 which is reported to have tumor
suppressor properties, genes involved in lymphocyte ac-
tivation and differentiation such as BCL6, CD4 andSMAD3 and genes TLR3 and TIRAP that are part of the
toll-like receptor signaling pathway. Bivalent domains
were also present on a variety of transcription factors
with immune-related functions such as CITED2, a trans-
activator that regulates NF-κB, MYC a transcription fac-
tor associated with hematopoetic tumors and RHOB a
Ras family homolog that mediates apoptosis in tumor
cells after DNA damage. Moreover, all genes involved in
the top five functional annotation clusters showed higher
chromatin levels in line 72 primarily after MDV infection
(Additional file 5).
Bivalent domains are altered in response to MD
We further investigated the effect of MD on bivalent chro-
matin domains observed on BCL6, CITED2, EGR1, CD4
and TLR3 (Additional file 1: Figure 5 and S7). Interest-
ingly, three of these genes, CITED2, BCL6 and EGR1,
showed identical epigenetic and transcriptional signatures.
CITED2 is a member of the p300/CBP co-activator
family that has intrinsic histone acetyltransferase activity
and plays a major role in regulating and coordinating
multiple complex cellular signals to determine the ex-
pression level of a gene [36]. B-cell CLL/lymphoma 6
(BCL6) is a zinc finger protein that functions as a tran-
scriptional repressor which was downregulated at 15 dpi
in spleen tissues from F1 progeny (15I5 X 71) of MD-
susceptible chickens [20]. EGR1 belongs to a group of
early response genes induced by a variety of signaling
molecules such as growth factors, hormones and neuro-
transmitters that is believed to play a major role in cell
proliferation and apoptosis [37]. Overexpression of
EGR1 promotes tumor growth in kidney cells [38] but
suppresses growth and transformation in other cell
types, e.g. fibroblasts and glioblastoma cells [39].
In each of the above genes, both active and repressive
chromatin marks were increased in response to infection
in line 63 chickens. However, in line 72, there was a def-
inite increase in H3K27me3 marks but no change in
H3K4me3 (Figures 5A, C, E). Transcript levels were in
agreement with this observation: infected line 72 chick-
ens showed a significant downregulation (CITED2:
p=0.0004; BCL6: p=0.0048; EGR1: p=0.0005; Figures 5B,
D, F), while there were no such changes in line 63.
On the other hand, TLR3 and CD4 showed a slight in-
crease in H3K4me3 marks after MDV infection while
there were no appreciable changes in H3K27me3 levels.
In keeping with the epigenetic changes, there was a
small increase in gene expression in infected birds from
both lines (Additional file 1: Figure S7).
Discussion
Immune parameters that are known to play a major role
in genetic resistance to MDV are correlated with innate
immune responses, such as NK cell activity, production
Figure 5 Bivalent domains on transcriptional regulators are altered by MD. H3K4me3 (orange) and H3K27me3 (green) profiles and
associated transcript levels of BCL6 (A, B), EGR1 (C, D) and CITED2 (E, F). In all three cases we observe a slight increase in H3K27me3 induced by
MDV infection in line 72 and a concurrent significant decrease in transcript levels while increase in active and repressive marks appear to cancel
each other out in line 63.
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cent studies have identified host cytokines such as IL-18
and IFN-γ that contribute to the initiation and continu-
ation of latency [40]. However, cytokine levels can
undergo rapid flux in response to infection, and consist-
ent with this, we did not observe any epigenetic changes
associated with these genes in the MHC-congenic lines
used in our study (Additional file 1: Figure S8). This sug-
gests the existence of other extrinsic factors responsible
for transcriptional variations between resistant and sus-
ceptible chickens at this stage of the disease.
A global comparison of histone modification levels in
the two inbred chicken lines yielded some interesting
results. As expected, a majority of SERs were found in
all the experimental groups, indicating a high level of
epigenetic similarity between the lines in addition to
inherent genetic similarity. In the case of H3K27me3,
the percentage of ubiquitous SERs was relatively low
(23.4%), although this was likely due to lower precision
of the peak caller for broad chromatin marks. Besides,
most of the SERs detected in a subset of samplescorresponded to regions of low enrichment, which may
also be the reason behind the relatively low number of
differential SERs detected in our study.
Genes that have been previously associated with MD
and various other cancers showed differential marks that
are either MD-induced (MX1, CTLA-4, EAF2 and GAL)
or line-specific (IGF2BP1 and MMP2). The increase in
H3K4me3 marks around the TSS of MX1, a gene with
known antiviral properties, appeared to be correlated
with upregulated expression in both lines in response to
MDV infection. However, lowered overall mRNA levels
in the resistant line suggest additional factors could be
involved in the regulation of this gene. Similarly,
increased mRNA levels of the lymphocyte surface mar-
ker CTLA4 is possibly due to the presence of larger
numbers of T cells in MDV infected birds as a result of
higher levels of infection. EAF2 functions as an apop-
tosis inducer in addition to being a tumor suppressor,
and therefore, its downregulation could contribute to
higher tumor incidence rates in line 72. However, it is
not clear why a significant increase in H3K27me3 levels
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ant line.
IGF2BP1 is believed to act by stabilizing the mRNA of
the c-myc oncogene and therefore, the higher expression
of this gene and a more stable c-myc gene product
might play a role in increasing MD susceptibility in line
72 birds via increased cell proliferation and transform-
ation. The matrix metalloprotease MMP2 is upregulated
after infection in the resistant line 63, similar to the pre-
viously observed increase at the neoplastic stage of MD.
However, mRNA levels were similar in the two lines be-
fore infection contrary to the difference in H3K4me3
levels suggesting that additional factors are responsible
for regulating this gene.
The correlation between observed differential histone
marks and transcript levels was moderate at best. In-
deed, differential H3K4me3 marks were strongly predict-
ive of gene expression levels but the correlation between
H3K27me3 and mRNA levels was relatively poor. There
could be various reasons for this – indeed, H3K27me3
levels had a non-linear relationship with gene expression
with higher marks showing little difference in the effect
on expression. Therefore, in this tissue, the levels of
H3K27me3 may not be a very good indicator of gene ex-
pression levels. Also, the transcription of these genes
might be controlled by other factors with the change in
H3K27me3 levels only incidental.
Bivalent domains were detected on transcriptional
regulators BCL6, CITED2 and EGR1 and the galanin
receptor GALR1. The epigenetic and transcriptional sig-
natures observed on these genes indicated that they
were poised at the latent stage of the disease, but with
crucial differences in the two lines. Increased repressive
marks in the susceptible line correlated with significant
downregulation of the genes, while in line 63, the in-
crease in both marks appeared to compensate for each
other with no eventual effect on gene transcription.
This suggests that some ‘poised’ bivalent genes can be-
come highly repressed even with a relatively small in-
crease in H3K27me3 marks. The change in the
chromatin levels could also be correlated with an in-
crease in cell populations having the repressive mark.
Taken together, the above findings point towards the
existence of finely balanced epigenetic control of tran-
scription, which may be necessary to mount a rapid
response by the immune system. However, this ma-
chinery could potentially be hijacked by a pathogen
and result in an aberrant phenotype. The effect of
MDV infection on the bivalent domain on GALR1, in
particular, suggests the repression and potential loss of
its anti-proliferative effects. Thus, the galanin system
possibly plays an important and hitherto unknown
role in MD progression and could be a novel target
for long-term control of the disease.One of the major players in MDV-induced malignant
transformation is Meq, a virus-encoded oncoprotein that
has diverse functions, e.g. transactivation, chromatin re-
modeling and regulation of transcription. Meq interacts
with and sequesters the tumor suppressor protein p53,
resulting in the dysregulation of cell-cycle control [7]
and inhibition of the transcriptional and apoptotic activ-
ities of the protein [41]. Several genes that show epigen-
etic changes in response to MDV infection have been
associated with p53. Downregulation of CITED2 stabi-
lizes the p53 protein leading to its accumulation [42].
The BCL6 gene product is believed to contribute to lym-
phomagenesis by inactivation of p53 [43]. Besides, EAF2
has also been shown to interact with and suppress the
function of p53 [28]. The downregulation of all of the
above genes in susceptible birds after MDV infection
points towards the increased production of p53 and a
robust anti-tumor response. That we still observe higher
tumor incidence rates in this line, suggests the presence
of large amounts of inactivating viral Meq protein which,
in turn, indicates that increased numbers of MD-
infected cells are present in the susceptible line at this
stage of the disease. A majority of tumors are believed to
result from the viral transformation of CD4+ T cells
some of which are infected at the latent stage of MD
[44]. The larger number of virus-infected cells produced
in the susceptible line is possibly due to lowered im-
munocompetence as a result of the early stages of infec-
tion. Thus, a more detailed investigation of the early
cytolytic stage of MD is necessary to shed further light
on the causes behind the divergent response to MD
observed in these birds.
Whole tissues represent a mixture of various cell
populations, and observed epigenetic changes might be
due to a change in chromatin marks in a particular cell
type or a variation in the relative number of cells carry-
ing active or repressive histone marks. However, such
in vivo studies are representative of the host response at
a systems level wherein different cell types might inter-
act in a cooperative manner to fight infection. Thus,
while the study of pure cell populations is likely to yield
greater discriminative power, the investigation of tissue
macroenvironments is, perhaps, closer to reality.
This study focused on the thymus tissue as it is a
major immune organ and contains a significant popu-
lation of T lymphocytes in various stages of differen-
tiation. Our earlier study of the MDV-induced
transcriptome in these birds indicated the presence of
line-specific differences at the latent stage of MD [45].
In addition, birds susceptible to MD suffer thymic atro-
phy during the early stages of infection [46], indicating
the importance of understanding changes in this organ
to elucidate the mechanisms involved in disease pro-
gression. Ongoing studies in our lab include other
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various stages of infection, to further investigate the
systemic effects of MD and the epigenetic basis of MD
resistance.
Conclusions
We studied the effect of latent MDV infection on two
chromatin modifications in inbred chicken lines exhi-
biting different degrees of resistance to MD. Several
genes showed changes in histone enrichment and this
response was often significantly different between the
two chicken lines. A detailed analysis of co-localization
patterns of the chromatin marks revealed the presence
of bivalent domains on a number of immune-related
transcriptional regulators. More importantly, these
domains showed marked changes in response to MDV
infection and provide further evidence of the far-
reaching epigenetic effects of MD. Our results suggest
putative roles for the GAL system in MD progression.
A majority of the differential chromatin marks are also
suggestive of increased levels of viral infection in the
susceptible line symptomatic of lowered immunocom-
petence in these birds at early stages of the disease. In
summary, our study provides further insight into the
mechanisms of MD progression while revealing a com-
plex landscape of epigenetic regulatory mechanisms.
Further work is necessary to fully elucidate the under-
lying mechanisms of MD, but our results suggest that
this is a promising step towards a deeper understand-
ing of this complex disease.
Methods
Animals and viruses
Two specific-pathogen-free inbred lines of White Leg-
horn either resistant (63) or susceptible (72) to MD were
hatched, reared and maintained in Avian Disease and
Oncology Laboratory (ADOL, Michigan, USDA). Four
chickens from each line were injected intra-abdominally
with a partially attenuated very virulent plus strain of
MDV (648A passage 40) at 5 days after hatch with a
viral dosage of 500 plaque-forming units (PFU). Infected
and control chickens from both lines (n = 4) were termi-
nated at 10dpi to collect thymus tissues. All procedures
followed the standard animal ethics and use guidelines
of ADOL.
Quantification of MDV loads in thymus
The MDV gene ICP4 was used for quantification of viral
genomic DNA in thymus as previously described [48].
Quantitative PCR was performed by using 100 ng/μl of
genomic DNA on the iCycler iQ PCR system (Bio-Rad,
USA) and QuantiTect SYBR Green PCR Kit (Qiagen,
USA) (Additional file 1: Figure S9). The relative MDV
loads were determined by normalizing to a single-copygene Vim (vimentin) [49]. The primers for Vim are as
follows: Forward: 5’-CAGCCACAGAGTAGGGTAGTC-
3’; Reverse: 5’-GAATAGGGAAGAACAGGAAAT-3’.
Chromatin Immunoprecipitation and Illumina Sequencing
Chromatin immunoprecipitation (ChIP) was carried out
using thymus samples from MDV infected and controls
birds [50]. About 30 mg thymus samples from three
individuals were cut into small pieces (1 mm3) and
digested with MNase to obtain mononucleosomes. PNK
and Klenow enzymes (NBE, Ipswich, MA, USA) were
used to repair the ChIP DNA ends pulled down by the
specific antibody. A 30 adenine was then added using
Taq polymerase and a pair of Solexa adaptors (Illumina,
USA) ligated to the repaired ends. Seventeen cycles of
PCR was performed on ChIP DNA using the adaptor
primers and fragments with a length of about 190 bp
(mononucleosome + adaptors) were isolated from
agarose gel. Subsequently, cluster generation and ChIP-
sequencing (ChIP-Seq) using the purified DNA was per-
formed on the Solexa 1G Genome Analyzer (Illumina,
USA) following manufacturer protocols. The antibodies
used and the total number of reads obtained for each
sample is listed in Additional file 6.
Read mapping and summary counts
Sequence reads obtained from the Illumina 1G Genome
Analyzer were aligned to the May 2006 version of the
chicken genome (galGal3) using Maq version 0.7.1 [51].
Default alignment policies of Maq were enforced: a valid
alignment could have a maximum of two mismatches
and if a read aligned equally well to multiple places in
the genome, one was chosen at random. If multiple
reads mapped to the same genomic location only one
was kept to avoid amplification bias. Summary read
counts were calculated using non-overlapping windows
of 200 bp for visualization and normalized to per million
mapped reads in each sample for the purpose of
comparisons.
Identification of enriched regions
Summarized read counts were subjected to peak calling
with SICER [52]. The source code was modified to in-
clude support for the chicken genome. Fragment length
was specified to be 190. A window size of 200 bp and
gap size of 400 bp was used for the analysis. The E-
value for estimating significant peaks was set to 100.
For the purposes of comparing different samples, SERs
found in similar genomic regions of different samples
were merged to obtain a consolidated list as follows:
SERs from one sample were used to initialize the list.
For each such region M, we searched for overlapping
SERs in the next sample. In the case of an overlap be-
tween M and a significant region, S, the merged region
Mitra et al. BMC Genomics 2012, 13:557 Page 10 of 12
http://www.biomedcentral.com/1471-2164/13/557was updated to include both M and S. This procedure
was iterated over all samples to obtain a consolidated
list of merged SERs.Gene annotation and genomic distribution of SERs
RefSeq and Ensembl gene annotations were downloaded
from UCSC genome browser [53]. As there were only
4306 RefSeq genes in the database, we included Ensembl
genes in our analysis to improve genome-wide coverage.
There were 17858 annotated genes in the Ensembl data-
base, which include validated and predicted genes. Re-
dundancies between the databases were listed and
accounted for, yielding a non-redundant list of 18198
genes with 4306 RefSeq genes and 13892 Ensembl genes.
We then searched for overlaps between merged SERs
and the non-redundant list of annotated genes. For
H3K4me3, an SER was annotated with a gene if it over-
lapped the TSS region of the gene whereas in the case of
H3K27me3, a valid overlap constituted an SER overlap-
ping the gene body. To calculate the genomic distribu-
tion we counted all SERs having an overlap with one of
the following regions: promoter (TSS ± 1 kb), exons,
introns, 5’ UTR and 3’ UTR.Histone modification profiles and differential chromatin
marks
Genes were divided into 10 sets based on their absolute
expression and representative sets corresponding to
high, medium, low and no expression were chosen for
visualization. We defined the gene body as the region
between the transcription start site (TSS) and the tran-
scription termination site (TTS). Histone modification
profiles surrounding the gene body were calculated in 3
distinct regions: 5000 bp upstream of the 5’ end, gene
body and 5000 bp downstream of the 3’ end of the gene.
For reads falling within the gene body, read counts were
obtained in bins 5% of the gene length while 1000 bp
windows were used for the 5’ and 3’ flanking regions.
The read counts in all cases were normalized to the total
number of genes in the categories and total number of
reads in the sample. We also compared gene expression
to histone modification levels by plotting normalized
microarray data (Zhang, H. unpublished data) against
reads mapping to (i) TSS ± 500 bp and (ii) the gene
body for each gene.
Reads mapping to merged SERs were tested for epi-
genetic changes induced by MDV infection in lines 63
and 72 using DESeq [54]. We used the method ‘blind’
for variance estimation and p-values were corrected for
multiple testing using the Benjamini-Hochberg FDR pro-
cedure [55]. Statistical significance was defined using a
false discovery rate (FDR) threshold of 0.4.Validation of ChIP, ChIP-Seq and gene transcription by
Q-PCR
Quantitative real-time RT-PCR was used to validate the
quality of the ChIP and gene transcript levels on the
iCycler iQ PCR system (Bio-Rad, Hercules, CA, USA).
The real-time RT-PCR reactions were performed with a
QuantiTect SYBR Green PCR Kit (Qiagen, Valencia, CA,
USA) according to the manufacturer’s instructions. An
online primer system (http://frodo.wi.mit.edu/primer3/)
was used to design the primers and four biological and
four technical replicates were performed. The primer
sequences are shown in Additional file 7.
Data access
Raw and processed ChIP-Seq data discussed in this
manuscript were deposited in the NCBI Gene Expression
Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/)
under Series accession number GSE24017.
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